Novelion Therapeutics Inc (NVLNF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1998 | 12-1997 | 12-1996 | 12-1995 | 12-1994 | |
| Sales | 5,099 | 7,461 | 9,898 | 2,531 | 3,776 |
| Gross Profit | 5,099 | 7,461 | 9,898 | 2,531 | 3,776 |
| Operating Expenses | 0 | 0 | 0 | 17,221 | 0 |
| Operating Income | 5,099 | 7,461 | 9,898 | -14,690 | 3,776 |
| Pre-tax Income | 5,099 | 7,461 | 9,898 | -14,690 | 3,776 |
| Net Income Continuous | -16,205 | -12,034 | -3,446 | -10,730 | -10,419 |
| Net Income | $-16,205 | $-12,034 | $-3,446 | $-14,690 | $-10,419 |
| EPS Basic Total Ops | -1.53 | -1.15 | -0.35 | -1.35 | -1.33 |
| EPS Basic Continuous Ops | -1.52 | -1.16 | -0.35 | -1.36 | -1.32 |
| EPS Diluted Total Ops | -1.53 | -1.15 | -0.35 | -1.35 | -1.33 |
| EPS Diluted Continuous Ops | -1.52 | -1.16 | -0.35 | -1.36 | -1.32 |
| EBITDA(a) | $5,099 | $7,461 | $9,898 | $-14,690 | $3,776 |